TRAF4 and cancer: Low OIP5-AS1 expression increases miR-367-3p expression, thereby decreasing CEBPA, which facilitates glioma development by binding to the promoter of TRAF4 (which promotes cancer proliferation, migration, and invasion and inhibits apoptosis), ultimately weakening TRAF4 expression.